Early Phase I Study of Autologous T Cells (EX02 CAR-T) for Unresectable Pancreatic/Bile Duct Cancer
NCT06196658
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
NOT_YET_RECRUITING
Status
6
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Cancer
Advanced Biliary Cancer
Interventions
DRUG:
anti-EX02 CAR T cells
Sponsor
Zhang Xiaofeng,MD
Collaborators
[object Object]